- Report
- June 2026
- 183 Pages
Global
From €3224EUR$3,545USD£2,762GBP
€3582EUR$3,939USD£3,069GBP
- Report
- August 2025
- 190 Pages
Global
From €3224EUR$3,545USD£2,762GBP
€3582EUR$3,939USD£3,069GBP
- Report
- August 2025
- 199 Pages
Global
From €3224EUR$3,545USD£2,762GBP
€3582EUR$3,939USD£3,069GBP
- Report
- August 2025
- 181 Pages
Global
From €3224EUR$3,545USD£2,762GBP
€3582EUR$3,939USD£3,069GBP
Pediatric Pulmonology is a medical specialty focused on the diagnosis and treatment of respiratory diseases in children. It involves the evaluation and management of a wide range of conditions, including asthma, cystic fibrosis, bronchopulmonary dysplasia, sleep-disordered breathing, and chronic lung disease. Pediatric Pulmonologists also provide care for children with complex medical conditions, such as neuromuscular disorders, congenital heart disease, and immunodeficiency. Treatment options may include medications, oxygen therapy, and other interventions, such as bronchoscopy, chest physiotherapy, and pulmonary rehabilitation.
The Pediatric Pulmonology market is comprised of a variety of companies that provide products and services related to the diagnosis and treatment of respiratory diseases in children. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples of companies in this market include GlaxoSmithKline, Merck, Novartis, Philips Respironics, and ResMed. Show Less Read more